146 related articles for article (PubMed ID: 21506077)
1. [Impulse control disorders in Parkinson's disease].
Van den Heuvel OA; Van der Werf YD; Groenewegen HJ; Foncke EM; Berendse HW
Tijdschr Psychiatr; 2011; 53(4):211-22. PubMed ID: 21506077
[TBL] [Abstract][Full Text] [Related]
2. Drug-induced impulse control disorders in Parkinson's disease.
Reiff J; Jost WH
J Neurol; 2011 May; 258(Suppl 2):S323-7. PubMed ID: 21560063
[TBL] [Abstract][Full Text] [Related]
3. Impulse-control disorders in Parkinson's disease.
Ferrara JM; Stacy M
CNS Spectr; 2008 Aug; 13(8):690-8. PubMed ID: 18704024
[TBL] [Abstract][Full Text] [Related]
4. Impulse control disorders in Parkinson's disease: prevalence and possible risk factors.
Weintraub D
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S110-3. PubMed ID: 20082968
[TBL] [Abstract][Full Text] [Related]
5. Impulse control disorders in Parkinson's disease: definition, epidemiology, risk factors, neurobiology and management.
Ceravolo R; Frosini D; Rossi C; Bonuccelli U
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S111-5. PubMed ID: 20123548
[TBL] [Abstract][Full Text] [Related]
6. Impulse control disorders and dopamine dysregulation syndrome associated with dopamine agonist therapy in Parkinson's disease.
Fenu S; Wardas J; Morelli M
Behav Pharmacol; 2009 Sep; 20(5-6):363-79. PubMed ID: 19724195
[TBL] [Abstract][Full Text] [Related]
7. Impulse control disorders in patients with Parkinson's disease.
Gescheidt T; Bares M
Acta Neurol Belg; 2011 Mar; 111(1):3-9. PubMed ID: 21510226
[TBL] [Abstract][Full Text] [Related]
8. [Dopamine dysregulation syndrome in Parkinson's disease and restless legs syndrome].
Bayard S; Cochen De Cock V; Dauvillers Y
Geriatr Psychol Neuropsychiatr Vieil; 2011 Jun; 9(2):227-35. PubMed ID: 21690031
[TBL] [Abstract][Full Text] [Related]
9. Impulse control disorders and depression in Finnish patients with Parkinson's disease.
Joutsa J; Martikainen K; Vahlberg T; Voon V; Kaasinen V
Parkinsonism Relat Disord; 2012 Feb; 18(2):155-60. PubMed ID: 21983019
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and pharmacological factors associated with impulse-control disorder symptoms in patients with Parkinson disease.
Perez-Lloret S; Rey MV; Fabre N; Ory F; Spampinato U; Brefel-Courbon C; Montastruc JL; Rascol O
Clin Neuropharmacol; 2012; 35(6):261-5. PubMed ID: 23123689
[TBL] [Abstract][Full Text] [Related]
11. Impulse control disorders in Parkinson's disease.
Vilas D; Pont-Sunyer C; Tolosa E
Parkinsonism Relat Disord; 2012 Jan; 18 Suppl 1():S80-4. PubMed ID: 22166463
[TBL] [Abstract][Full Text] [Related]
12. Impulse control disorders and punding in Parkinson's disease: the need for a structured interview.
Ávila A; Cardona X; Bello J; Maho P; Sastre F; Martín-Baranera M
Neurologia; 2011 Apr; 26(3):166-72. PubMed ID: 21163239
[TBL] [Abstract][Full Text] [Related]
13. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients.
Weintraub D; Koester J; Potenza MN; Siderowf AD; Stacy M; Voon V; Whetteckey J; Wunderlich GR; Lang AE
Arch Neurol; 2010 May; 67(5):589-95. PubMed ID: 20457959
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of repetitive and reward-seeking behaviors in Parkinson disease.
Voon V; Hassan K; Zurowski M; de Souza M; Thomsen T; Fox S; Lang AE; Miyasaki J
Neurology; 2006 Oct; 67(7):1254-7. PubMed ID: 16957130
[TBL] [Abstract][Full Text] [Related]
15. [Impulse control disorders in Parkinson's disease].
Joutsa J; Kaasinen V
Duodecim; 2013; 129(22):2351-8. PubMed ID: 24397147
[TBL] [Abstract][Full Text] [Related]
16. Past smoking and current dopamine agonist use show an independent and dose-dependent association with impulse control disorders in Parkinson's disease.
Valença GT; Glass PG; Negreiros NN; Duarte MB; Ventura LM; Mueller M; Oliveira-Filho J
Parkinsonism Relat Disord; 2013 Jul; 19(7):698-700. PubMed ID: 23611687
[TBL] [Abstract][Full Text] [Related]
17. Impulse control disorders in patients with Parkinson's disease receiving dopamine replacement therapy: evidence and implications for the addictions field.
Ambermoon P; Carter A; Hall WD; Dissanayaka NN; O'Sullivan JD
Addiction; 2011 Feb; 106(2):283-93. PubMed ID: 21134016
[TBL] [Abstract][Full Text] [Related]
18. Dopamine agonists and therapy compliance.
Grosset D
Neurol Sci; 2008 Dec; 29 Suppl 5():S375-6. PubMed ID: 19381766
[TBL] [Abstract][Full Text] [Related]
19. [Urinary disorders, sexual dysfunction and hypersexuality in Parkinson's disease].
Vázquez-Sáánchez F; Rodríguez-Martínez E; Arés-Luque A
Rev Neurol; 2010 Feb; 50 Suppl 2():S27-31. PubMed ID: 20205139
[TBL] [Abstract][Full Text] [Related]
20. Internet gambling and other pathological gambling in Parkinson's disease: a case series.
Wong SH; Cowen Z; Allen EA; Newman PK
Mov Disord; 2007 Mar; 22(4):591-3. PubMed ID: 17266073
[No Abstract] [Full Text] [Related]
[Next] [New Search]
